AXA SA at week 3: the market has yet to confirm
AXA SA is at week 3 of a sell signal: 3 weeks of sideways action, no market confirmation. Trading not recommended — the stock is still 15% above the 200-week moving average. 11th out of 54 EU-UK sell signals.
CoreWeave: week 8, breakeven stop and profit-taking window open
CoreWeave is in the 8th week of a buy signal: the stop has moved to breakeven, risk is zeroed out. Signal strength is high but the technical structure shows caution signals. The 8th-week statistical reduction window is now open.
CrowdStrike: buy signal in advanced phase, stop at breakeven and next window at week 8
CrowdStrike is at week 6 of a buy signal with 2 of the 3 model targets already hit and a 49% gain from entry. Stop is at breakeven, risk zeroed out. The next statistical window is at week 8.
CRISPR Therapeutics at Week 7: Bearish Confirmation, Model Flags Caution
CRISPR Therapeutics is at week 7 of an active long. The confirmation week closed bearish and the model flagged an early exit warning: the dynamic stop is tight, near entry. The trade is down 10.61% and the technical picture is weak.
Salesforce triggers a buy signal: high strength, but the band advises against opening
Salesforce receives a fresh buy signal, ranked 3rd among 7 new US Longs. Signal strength at 72 out of 100 — wide and volatile. The quality band flags trading not recommended: the stock is still 21% below the 200-week average. Confirmation week is in progress.
Credo Technology: 2 targets already hit, the third awaits at week 10
Credo Technology is in week 7 of a buy initiated near the 160 area. 2 of the 3 advanced model targets already hit, the trade is up 28.75% with a breakeven stop. Next trim window at week 8.